These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 28169410)

  • 1. [Long-term effect of policosanol on the functional recovery of non-cardioembolic ischemic stroke patients: a one year study].
    Sanchez J; Illnait J; Mas R; Mendoza S; Fernandez L; Mesa M; Vega H; Fernandez J; Reyes P; Ruiz D
    Rev Neurol; 2017 Feb; 64(4):153-161. PubMed ID: 28169410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of policosanol in the functional recovery of non-cardioembolic ischemic stroke hypertensive patients.
    Sanchez-Lopez J; Fernandez-Travieso JC; Illnait-Ferrer J; Fernandez-Dorta L; Mendoza-Castano S; Mas-Ferreiro R; Mesa-Angarica M; Reyes-Suarez P
    Rev Neurol; 2018 Nov; 67(9):331-338. PubMed ID: 30350844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of policosanol 20 versus 40 mg/day in the treatment of patients with type II hypercholesterolemia: a 6-month double-blind study.
    Castaño G; Mas R; Fernández L; Illnait J; Gámez R; Alvarez E
    Int J Clin Pharmacol Res; 2001; 21(1):43-57. PubMed ID: 11708574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of addition of policosanol to omega-3 fatty acid therapy on the lipid profile of patients with type II hypercholesterolaemia.
    Castaño G; Fernández L; Mas R; Illnait J; Gámez R; Mendoza S; Mesa M; Fernández J
    Drugs R D; 2005; 6(4):207-19. PubMed ID: 16050054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the effects of D-003 and policosanol (5 and 10 mg/day) in patients with type II hypercholesterolemia: a randomized, double-blinded study.
    Castaño G; Más R; Fernández L; Illnait J; Mendoza S; Gámez R; Fernández J; Mesa M
    Drugs Exp Clin Res; 2005; 31 Suppl():31-44. PubMed ID: 16444910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia: a randomized controlled trial.
    Berthold HK; Unverdorben S; Degenhardt R; Bulitta M; Gouni-Berthold I
    JAMA; 2006 May; 295(19):2262-9. PubMed ID: 16705107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of policosanol on patients with ischemic stroke: a pilot open study.
    Ortega LL; Sánchez J; Más R; Fernández L; Mendoza S; Gámez R; Fernández JC; Illnait J; Alvarez E
    J Med Food; 2006; 9(3):378-85. PubMed ID: 17004902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant use of policosanol and beta-blockers in older patients.
    Castaño G; Mas R; Gámez R; Fernández J; Illnait J; Fernández L; Mendoza S; Mesa M; Gutiérrez JA; López E
    Int J Clin Pharmacol Res; 2004; 24(2-3):65-77. PubMed ID: 15689053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of policosanol in hypercholesterolemic postmenopausal women.
    Mirkin A; Mas R; Martinto M; Boccanera R; Robertis A; Poudes R; Fuster A; Lastreto E; Yañez M; Irico G; McCook B; Farré A
    Int J Clin Pharmacol Res; 2001; 21(1):31-41. PubMed ID: 11708573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a policosanol supplement on serum lipid concentrations in hypercholesterolaemic and heterozygous familial hypercholesterolaemic subjects.
    Greyling A; De Witt C; Oosthuizen W; Jerling JC
    Br J Nutr; 2006 May; 95(5):968-75. PubMed ID: 16611388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term therapy with policosanol improves treadmill exercise-ECG testing performance of coronary heart disease patients.
    Stüsser R; Batista J; Padrón R; Sosa F; Pereztol O
    Int J Clin Pharmacol Ther; 1998 Sep; 36(9):469-73. PubMed ID: 9760006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of the efficacy and tolerability of policosanol and lovastatin in patients with hypercholesterolemia and noninsulin dependent diabetes mellitus.
    Crespo N; Illnait J; Más R; Fernández L; Fernández J; Castaño G
    Int J Clin Pharmacol Res; 1999; 19(4):117-27. PubMed ID: 10939029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind, placebo-controlled study of the effects of policosanol in patients with intermittent claudication.
    Castaño G; Más R; Roca J; Fernández L; Illnait J; Fernández JC; Selman E
    Angiology; 1999 Feb; 50(2):123-30. PubMed ID: 10063942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of policosanol and pravastatin on lipid profile, platelet aggregation and endothelemia in older hypercholesterolemic patients.
    Castaño G; Más R; Arruzazabala ML; Noa M; Illnait J; Fernández JC; Molina V; Menéndez A
    Int J Clin Pharmacol Res; 1999; 19(4):105-16. PubMed ID: 10939028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A randomized, double-blind, placebo-controlled study of the antilipemic efficacy and tolerability of food supplement policosanol in patients with moderate hypercholesterolemia].
    Tedeschi-Reiner E; Reiner Z; Romić Z; Ivanković D
    Lijec Vjesn; 2005; 127(11-12):273-9. PubMed ID: 16583932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative lipid-lowering effects of policosanol and atorvastatin: a randomized, parallel, double-blind, placebo-controlled trial.
    Cubeddu LX; Cubeddu RJ; Heimowitz T; Restrepo B; Lamas GA; Weinberg GB
    Am Heart J; 2006 Nov; 152(5):982.e1-5. PubMed ID: 17070175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of policosanol in older patients with type II hypercholesterolemia and high coronary risk.
    Castaño G; Más R; Fernández JC; Illnait J; Fernández L; Alvarez E
    J Gerontol A Biol Sci Med Sci; 2001 Mar; 56(3):M186-92. PubMed ID: 11253161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of hypercholesterolemia in NIDDM with policosanol.
    Torres O; Agramonte AJ; Illnait J; Más Ferreiro R; Fernández L; Fernández JC
    Diabetes Care; 1995 Mar; 18(3):393-7. PubMed ID: 7555484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of policosanol Versus acipimox in patients with type II hypercholesterolemia.
    Alcocer L; Fernández L; Campos E; Más R
    Int J Tissue React; 1999; 21(3):85-92. PubMed ID: 10645516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of policosanol (10 mg/d) versus aspirin (100 mg/d) in patients with intermittent claudication: a 10-week, randomized, comparative study.
    Illnait J; Castaño G; Alvarez E; Fernández L; Mas R; Mendoza S; Gamez R
    Angiology; 2008; 59(3):269-77. PubMed ID: 18388038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.